September 8th, 2011
Posted by Caroline Popper, M.D., M.P.H.
Following McKesson’s bold move with the acquisition of US Oncology last December, another distribution giant has entered the arena of helping oncologists manage patient care. AmerisourceBergen Corporation recently announced its purchase of IntrinsiQ, LLC—a provider of informatics products directly involved in assisting oncologists with clinical dosing decisions.
We’re uncertain as to whether AmerisourceBergen’s expansion in this arena shows an aggressive push for new market traction, a creative way to garner physicians’ mindshare or whether they’re simply betting on the growing informatics market. It does, however, seem likely that a distributor would want to add value to its “middleman” role. And this signals one thing that is for sure: Distributors are getting closer to physicians on a core level—right down to how they prescribe vital medications.
Why is this happening? AmerisourceBergen stated its reasoning in a recent announcement on Drugs.com: “Oncologists need strategic partners that can capture actionable intelligence…” In short, physicians face an increasingly complex world of decisions every day, and information technology may be the only available edge when treatment options are many and time is critical.
Read the rest of this entry »